Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
The American Journal of Psychiatry
|
July 1, 1995
Hospital use of antipsychotic agents in 1989 and 1993: stable dosing with decreased length of stay
R J Baldessarini, J C Kando, F Centorrino
Biological Psychiatry
|
December 1, 1996
The effect of clozapine on saliva flow rate: a pilot study
T Rabinowitz, F R Frankenburg, F Centorrino, et al.
The Journal of Clinical Psychiatry
|
June 1, 1994
Concurrent use of clozapine and valproate in affective and psychotic disorders
J C Kando, M Tohen, J Castillo, et al.
Biological Psychiatry
|
April 21, 1998
Clozapine and body mass change
F R Frankenburg, M C Zanarini, J Kando, et al.
Drug Safety
|
November 1, 1996
Clinically significant interactions of psychotropic agents with antipsychotic drugs
M C Meyer, R J Baldessarini, D C Goff, et al.
The Journal of Clinical Psychiatry
|
January 1, 1996
Bladder dysfunction associated with clozapine therapy
F R Frankenburg, J C Kando, F Centorrino, et al.
Schizophrenia Research
|
June 6, 2006
Comorbid substance-use in schizophrenia: relation to positive and negative symptoms
A Talamo, F Centorrino, L Tondo, et al.
Pharmacopsychiatry
|
July 24, 2010
Characteristics and clinical changes during hospitalization in bipolar and psychotic disorder patients with versus without substance-use disorders
A Vincenti, A Ventriglio, R J Baldessarini, et al.
The Journal of Clinical Psychiatry
|
March 10, 1998
Leukopenia associated with addition of paroxetine to clozapine
T P George, L Innamorato, M J Sernyak, et al.
The American Journal of Psychiatry
|
April 1, 1995
Relation of leukocyte counts during clozapine treatment to serum concentrations of clozapine and metabolites
F Centorrino, R J Baldessarini, J G Flood, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
The American Journal of Psychiatry
|
July 1, 1995
Hospital use of antipsychotic agents in 1989 and 1993: stable dosing with decreased length of stay
R J Baldessarini, J C Kando, F Centorrino
Biological Psychiatry
|
December 1, 1996
The effect of clozapine on saliva flow rate: a pilot study
T Rabinowitz, F R Frankenburg, F Centorrino, et al.
The Journal of Clinical Psychiatry
|
June 1, 1994
Concurrent use of clozapine and valproate in affective and psychotic disorders
J C Kando, M Tohen, J Castillo, et al.
Biological Psychiatry
|
April 21, 1998
Clozapine and body mass change
F R Frankenburg, M C Zanarini, J Kando, et al.
Drug Safety
|
November 1, 1996
Clinically significant interactions of psychotropic agents with antipsychotic drugs
M C Meyer, R J Baldessarini, D C Goff, et al.
The Journal of Clinical Psychiatry
|
January 1, 1996
Bladder dysfunction associated with clozapine therapy
F R Frankenburg, J C Kando, F Centorrino, et al.
Schizophrenia Research
|
June 6, 2006
Comorbid substance-use in schizophrenia: relation to positive and negative symptoms
A Talamo, F Centorrino, L Tondo, et al.
Pharmacopsychiatry
|
July 24, 2010
Characteristics and clinical changes during hospitalization in bipolar and psychotic disorder patients with versus without substance-use disorders
A Vincenti, A Ventriglio, R J Baldessarini, et al.
The Journal of Clinical Psychiatry
|
March 10, 1998
Leukopenia associated with addition of paroxetine to clozapine
T P George, L Innamorato, M J Sernyak, et al.
The American Journal of Psychiatry
|
April 1, 1995
Relation of leukocyte counts during clozapine treatment to serum concentrations of clozapine and metabolites
F Centorrino, R J Baldessarini, J G Flood, et al.
Page
of 3